Pulsenmore LTD 20-F annual reports

The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.

NASDAQ
Pulsenmore cut 2025 losses on a GE settlement, secured FDA clearance for its home-use prenatal ultrasound, and deepened ties with Israel’s Clalit while preparing a U.S. launch.